Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$341M |
| 2 |
Automatic Data Processing
ADP
|
+$325M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$248M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$195M |
| 5 |
Comcast
CMCSA
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.83B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.41B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$435M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$256M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.66% |
| 2 | Technology | 4.22% |
| 3 | Healthcare | 2.96% |
| 4 | Consumer Discretionary | 2.91% |
| 5 | Industrials | 2.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
CALL
Terex
TEX
$7.18B
| $786K | ﹤0.01% |
16,300
-6,700
| -29% | -$309K |
|
|
MCRN
3552
DELISTED
Milacron Holdings Corp.
MCRN
| $786K | ﹤0.01% |
41,085
-5,066
| -11% | -$90.5K |
|
3553
CALL
Fidelity National Financial
FNF
$13.9B
| $785K | ﹤0.01% |
20,800
+11,437
| +122% | +$417K |
|
3554
Provident Financial Services
PFS
$3.22B
| $785K | ﹤0.01% |
29,114
+9,700
| +50% | +$264K |
|
3555
WisdomTree US AI Enhanced Value Fund
AIVL
$428M
| $784K | ﹤0.01% |
8,871
+191
| +2% | +$16.5K |
|
|
AXON
3556
CALL
Axon Enterprise
AXON
$42.5B
| $784K | ﹤0.01% |
29,600
+6,500
| +28% | +$156K |
|
|
SF
3557
Stifel
SF
$12.6B
| $783K | ﹤0.01% |
29,583
+25,477
| +620% | +$623K |
|
|
ACH
3558
Accendra Health
ACH
$237M
| $781K | ﹤0.01% |
41,326
+2,217
| +6% | +$49.2K |
|
|
RAD
3559
PUT
DELISTED
Rite Aid Corporation
RAD
| $780K | ﹤0.01% |
19,800
+11,815
| +148% | +$422K |
|
3560
PUT
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$506M
| $779K | ﹤0.01% |
500
+400
| +400% | +$612K |
|
3561
CALL
Core Laboratories
CLB
$488M
| $778K | ﹤0.01% |
7,100
-5,700
| -45% | -$569K |
|
3562
CALL
STMicroelectronics
STM
$46.7B
| $778K | ﹤0.01% |
35,600
-26,900
| -43% | -$595K |
|
3563
PUT
AES
AES
$10.5B
| $777K | ﹤0.01% |
71,700
+6,900
| +11% | +$74.6K |
|
3564
Nomad Foods
NOMD
$1.66B
| $777K | ﹤0.01% |
45,983
| – | – |
|
3565
CALL
Manulife Financial
MFC
$73.9B
| $776K | ﹤0.01% |
37,100
-15,200
| -29% | -$316K |
|
|
VRNT
3566
DELISTED
Verint Systems
VRNT
| $776K | ﹤0.01% |
36,365
-274,311
| -88% | -$5.9M |
|
3567
8x8 Inc
EGHT
$269M
| $773K | ﹤0.01% |
54,866
-23,080
| -30% | -$319K |
|
3568
First Trust Enhanced Short Maturity ETF
FTSM
$6.49B
| $770K | ﹤0.01% |
12,837
+3,770
| +42% | +$226K |
|
3569
Lexicon Pharmaceuticals
LXRX
$1.03B
| $770K | ﹤0.01% |
77,958
+4,866
| +7% | +$50.6K |
|
3570
TransAlta
TAC
$3.95B
| $770K | ﹤0.01% |
129,465
-39,335
| -23% | -$234K |
|
|
EMES
3571
DELISTED
Emerge Energy Services LP
EMES
| $770K | ﹤0.01% |
107,134
+90,464
| +543% | +$707K |
|
3572
Avient
AVNT
$3.33B
| $768K | ﹤0.01% |
17,649
+16,651
| +1,668% | +$732K |
|
3573
PUT
Idexx Laboratories
IDXX
$44.1B
| $766K | ﹤0.01% |
4,900
+4,000
| +444% | +$630K |
|
|
ETJ
3574
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$567M
| $765K | ﹤0.01% |
79,460
+14,902
| +23% | +$138K |
|
3575
BioCryst Pharmaceuticals
BCRX
$2.28B
| $764K | ﹤0.01% |
155,581
+127,326
| +451% | +$617K |
|
Similar funds
Citigroup's Q4 2017 Portfolio in Review
As of Q4 2017, Citigroup held 7,845 positions worth $125B, up 2.1% from $122B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Citigroup withdrew a net $3.77B in Q4 2017, closing 246 positions and reducing 2,883 holdings. Its most notable exit was CR Bard Inc., an estimated $210M position sold in full.
By sector, the portfolio is most concentrated in Financials at 4.7% of assets, up from 4.4% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Citigroup opened a new position in Global X US Preferred ETF worth $19.9M.
- Citigroup's largest Q4 2017 buy was Global X US Preferred ETF: 800,000 shares worth $19.9M.
- Citigroup added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2017, an estimated $341M increase.
- Citigroup's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.83B.
- Citigroup fully exited CR Bard Inc. in Q4 2017, selling an estimated $210M.
- Citigroup's ten largest holdings make up 26% of its $125B portfolio in Q4 2017.
- Citigroup opened 463 new positions and closed 246 in Q4 2017.
- Citigroup's portfolio value rose 2.1% quarter-over-quarter to $125B.
Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.